Structural and physicochemical profiling of morphine and related compounds of therapeutic interest

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 8, 2009, Pages 984-995

  Mazak K ^a   Hosztafi, S ^a   Rácz, Á ^a   Noszal B ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Acid base properties; Lipophilicity; Morphine; Permeability; Pharmacokinetic properties; Physicochemical profiling; Solubility; Stability

Indexed keywords

ALCOHOL; BUPRENORPHINE; CHLOROFORM; CODEINE; DIAMORPHINE; ETHYLMORPHINE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; NALORPHINE; NALOXONE; NALTREXONE; OXYCODONE; OXYMORPHONE; PHOLCODINE; WATER;

ACID BASE BALANCE; ARTICLE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; IONIC STRENGTH; LIPOPHILICITY; MICROSCOPY; PH; PHYSICAL CHEMISTRY;

EID: 70349134005     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709788681555     Document Type: Article

References (71)

1. Willette, R. E. In Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry. Lippincott Williams & Wilkins, 1998, pp. 687-709.
2. Kilpatrick, G.J.; Smith, T.W. Morphine-6-glucuronide: actions and mechanisms. Med. Res. Rev., 2006, 25, 521-544.
3. Malekpourafshar, R.; Zeinalinejad, H. Effect of short time morphine addiction on the kidney tissue in rat. Am. J. Biochem. Biotech., 2005, 1, 186-188
4. Lotsch J.; Geisslinger, G. Morphine-6-glucuronide - An analgesic of the future? Clin. Pharmacokinet., 2001, 40, 485-499.
5. Vree, TB; van Dongen, RT; Koopman-Kimenai, PM. Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int. J. Clin. Pract., 2000, 54, 395-8.
6. Umans, J.G.; Inturrisi, C.E. Heroin: analgesia, toxicity and disposition in the mouse. Eur. J. Pharmacol., 1982, 85, 317-23.
7. Visky, D.; Kraszni, M.; Hosztafi, S.; Noszál, B. Species-specific hydrolysis kinetics of n-methylated heroin derivatives. Helv. Chim. Acta, 2000, 83, 364-372.
8. Avdeef, A.; Testa, B. Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques. Cell. Mol. Life Sci., 2002, 59, 1681-1689.
9. Kasim, N.A.; Whitehouse, M.; Ramachandran, C.; Bermejo, M.; Lennernas, H.; Hussain, A.S.; Junginger, H. E.; Stavchansky, S.A.; Midha, K.K.; Shah, V.P.; Amidon, G.L. Molecular properties of who essential drugs and provisional biopharmaceutical classification. Mol. Pharm., 2004, 1, 85-96.
10. Noszál, B. Acid-Base Properties of Bioligands. In Biocoordination Chemistry: Coordination Equilibria in Biologically Active Systems. Burger K. Ed., Ellis Horwood, Chichester, 1990, pp. 18-55.
11. Avdeef, A. Absorption and Drug Development: Solubility, Permeability and Charge State. Wiley-Interscience, New York, 2003.
12. Bjerrum, N. Dissociation constants of polybasic acids and their application to the calculation of molecular dimensions. Z. Phys. Chem., 1923, 106, 219-242.
13. Noszál, B.; Rabenstein, D. L. Nitrogen-protonation microequilibria and C (2)-deprotonation microkinetics of histidine, histamine and related compounds. J. Phys. Chem., 1991, 95, 4761-4765.
14. Szakács, Z; Kraszni, M; Noszál, B. Determination of microscopic acid-base parameters from NMR-pH titrations. Anal. Bioanal. Chem., 2004, 378, 1428-1448.
15. Kovács, Z.; Hosztafi, S.; Noszál, B. Site-specific acid-base properties of pholcodine and related compounds. Anal. Bioanal. Chem., 2006, 386, 1709-1716.
16. Fujita, T. In Comprehensive Medicinal Chemistry. Ramsen, C.A.; Hansch, C.; Sammer, P.G.; Taylor, J.B.; Eds; Pergamon, Oxford, 1990; Vol. 4, p. 497.
17. Avdeef, A. Physicochemical profiling. Curr. Top. Med. Chem., 2002, 1, 277-351.
18. Noszál, B; Kraszni, M. Conformer-specific partition coefficient: Theory and determination. J. Phys. Chem. B, 2002, 106, 1066-1068.
19. Kraszni, M; Bányai, I; Noszál, B. Determination of conformer-specific partition coefficients in octanol/water systems. J. Med. Chem., 2003, 46, 2241-2245.
20. Kraszni M.; Szakács Z.; Noszál, B. Determination of rotamer populations and related parameters from NMR coupling constants: a critical review. Anal. Bioanal. Chem., 2004, 378, 1449-1463.
21. Testa, B.; Carrupt, P.A.; Gaillard, P.; Tsai, R.S. In Lipophilicity in Drug Action And Toxicology. Pliska, V.; Testa, B.; van de Waterbeems, H.; Eds.; VCH publishers: Weinheim, 1996, pp. 49-71.
22. Fini, A. Formation of ion-pairs in aqueous solutions of diclofenac salts. Int. J. Pharm., 1999, 187, 163-173.
23. + in octanol. Environ. Toxicol. Chem., 1998, 17, 369-376.
24. Hansch, C. In Medicinal chemistry for the 21st century, Wermuth, C.G.; Koga, N.; König, H.; Eds., Metcalf Blackwell, Oxford, 1994, p. 281.
25. Kaufman, J.J.; Semo, N.M.; Koski, W.S. Microelectrometric titration measurement of pKas and partition and drug distribution coefficients of narcotics and narcotic-antagonists and their pH and temperature-dependence. J. Med. Chem., 1975, 18, 647-655.
26. Pagliara, A.; Carrupt, P.A.; Caron, G.; Gaillard, P.; Testa, B. Lipophilicity profiles of ampholytes. Chem. Rev., 1997, 97, 3385-3400.
27. Benson, D.W.; Kaufman, J.J.; Koski, W.S. Theoretic significance of pH dependence of narcotics and narcotic antagonists in clinical anesthesia. Anesth. Analg., 1976, 55, 253-256.
28. Stain, F.; Barjavel, M. J.; Sandouk, P.; Plotkine, M.; Scherrmann, J.-M.; Bhargava, H. N. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-β-D-glucuronide in the rat. J. Pharmacol. Exp. Ther., 1995, 274, 852-857.
29. Gaillard, P.; Carrupt, P.A.; Testa, B. The conformation-dependent lipophilicity of morphine glucuronides as calculated from the molecular lipophilicity potential. Bioorg. Med. Chem. Lett., 1995, 4, 737-742.
30. Franks, N.P.; Abraham, M.H.; Lieb, W.R. Molecular organization of liquid n-octanol: an X-ray diffraction analysis. J. Pharm. Sci., 1993, 82, 466-470.
31. Mälkiäa, A.; Murtomäki, L.; Urttib, A.; Kontturi, K. Drug permeation in biomembranes. In vitro and in silico prediction and influence of physicochemical properties. Eur. J. Pharm. Sci., 2004, 23, 13-47.
32. Gulaboski, R.; Cordeiro, M.N.D.S.; Milhazes, N.; Garrido, J.; Borges, F.; Jorge, M.; Pereira, C.M.; Bogeski, I.; Morales A.; Naumoski, B.; Silva, A.F. Evaluation of the lipophilic properties of opioids, amphetamine-like drugs, and metabolites through electrochemical studies at the interface between two immiscible solutions. Anal. Biochem., 2007, 361, 236-243.
33. Cornford, E.M.; Braun, L.D.; Oldendorf, W.H.; Hill, M.A. Comparison of lipid-mediated blood-brain barrier penetrability in neonates and adults. Am. J. Physiol., 1982, 243, 161-168.
34. Drustrup, J.; Fullerton, A.; Christrup, L.; Bundgaard, H. Utilization of prodrugs to enhance the transdermal absorption of morphine. Int. J. Pharm., 1991, 71, 105-116.
35. Rook, E.J.; Huitema, A.D.R.; Van den Brink, W.; Van Ree, J.M.; Beijnen, J.H. Population pharmacokinetics of heroin and its major metabolites. Clin. Pharmacokinet., 2006, 45, 401-417.
36. van Balen, G.P.; Martinet, C.A.M.; Caron, G.; Bouchard, G.; Reist, M.; Carrupt, P.A.; Fruttero, R.; Gasco, A.; Testa, B. Liposome/water lipophilicity: Methods, information content, and pharmaceutical applications. Med. Res. Rev., 2005, 24, 299-324.
37. Kramer, S.D. In Pharmacokinetic Optimization in Drug Research; Testa, B., van de Waterbeemd, H., Folkers, G., Guy, R. Eds.; WILEY-VCH publishers: Zürich, 2001; pp. 401-428.
38. Miyoshi, H.; Maeda, H.; Tokutate, N.; Fujita, T. Qunatitative analysis of partiton behaviour of substituted phenols from aqueous phase into liposomes made of lecithin and various lipids. Bull. Chem. Soc. Jpn., 1987, 60, 4357-4362.
39. Palm, K.; Luthman, K.; Ungell, A.-L.; Strandlund, G.; Beigi, F.; Lundahl, P.; Artursson, P. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. J. Med. Chem., 1998, 41, 5382-5392.
40. Avdeef, A.; Box, K.J.; Comer, J.E.A.; Hibbert, C.; Tam, K.Y. pHmetric log P 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs. Pharm. Res., 1999, 15, 209-215.
41. Balon, K.; Riebesehl, B.U.; Muller, B.W. Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm. Res., 1999, 16, 882-888.
42. Roy, S. D.; Flynn, G. L. Solubility and related physicochemical properties of narcotic analgesics. Pharm. Res., 1988, 5, 580-586.
43. Roy, S. D.; Flynn, G. L. Solubility behavior of narcotic analgesics in aqueous-media - solubilities and dissociation-constants of morphine, fentanyl, and sufentanil. Pharm. Res., 1989, 6, 147-151.
44. Garrett, ER; Chandran, VR. Pharmacokinetics of morphine and its surrogates VI: Bioanalysis, solvolysis kinetics, solubility, pK'a values, and protein binding of buprenorphine. J. Pharm. Sci., 1985, 74, 515-24.
45. Dale, O.; Nilsen, T.; Olaussen, G.; Tvedt, K. E.; Skorpen, F.; Smidsrød, O.; Vårum, K. M. Transepithelial transport of morphine and mannitol in Caco-2 cells: the influence of chitosans of different molecular weights and degrees of acetylation. J. Pharm. Pharmacol., 2006, 58, 909-915.
46. Helmy, A.; Carpenter, H.; Keri, L.; Hutchinson, P. J. Microdialysis in the human brain and its potential role in the development and clinical assessment of drugs. Curr. Med. Chem., 2007, 14, 1525-1537.
47. Bouw, R.; Ederoth. P.; Lundberg, J.; Ungerstedt, U.; Nordström, CH.; Hammarlund-Udenaes, M. Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis. Acta Anaesthesiol. Scand., 2001, 45, 390-2.
48. Vermeire, A.; Remon, J.P. Stability and compatibility of morphine. Int. J. Pharm., 1999, 187, 17-51.
49. Lach, J.L.; Patel, D.M.; Blaug, S.M. The chromatographic separation of morphine from its degradation products. J. Am. Pharm. Assoc., 1956, 45, 611-613.
50. Yeh, S.Y.; Lach, J.L. Stability of morphine in aqueous solution part 2. Separation of morphine from its degradation products. J. Pharm. Sci., 1961, 50, 30-34.
51. Yeh, S.Y.; Lach, J.L. Stability of morphine in aqueous solution part 3. Kinetics of morphine degradation in aqueous solution. J. Pharm. Sci., 1961, 50, 35-42.
52. Holcomb, I.J.; Luers, R.B.; Fusari, S.A. Chromatographic separation and assay of morphine in injectables. J. Pharm. Sci., 1973, 62, 1504-1509.
53. Ebel, S.; Rost, D. Determination of morphine and its degradation products in drugs by TLC. Arch. Pharm., 1980, 313, 337-343.
54. Bentley, K.W.; Dyke, S.F. The structure of pseudomorphine J. Chem. Soc., 1959, 2574-2577.
55. Roerig, D.L.; Reak, C.J.; Wang, R.I.H. Enzymatic conversion of morphine to pseudomorphine Biochem. Pharmacol., 1976, 25, 1075-1080.
56. Pungor, E.; Szász, A.; Papp-Molnár, E. A kinetical study of the decomposition of morphine. Acta Chim. Acad. Sci. Hung., 1967, 53, 251-262.
57. Yeh, S.Y.; Lach, J.L. Stability of morphine in aqueous solution part 4. Isolation of morphine and sodium bisulfite interaction product. J. Pharm. Sci., 1971, 60, 793-794.
58. Deeks, M.; Davis, S.; Nash, S. Stability of an intrathecal morphine injection formulation. Pharmaceut. J., 1983, 30, 495-497.
59. Garrido, J.M.P.J.; Delerue-Matos, C; Borges, F; Macedo, T.R.A.; Oliveira-Brett, A.M. Voltammetric oxidation of drugs of abuse - I. Morphine and metabolites. Electroanalysis, 2004, 16, 1419-1426.
60. Powell, M.F. Enhanced stability of codeine sulfate: effect of pH, buffer, and temperature on the degradation of codeine in aqueous solution. J. Pharm. Sci., 1986, 75, 901-903.
61. Persson-Stubberud, K.; Astrom O. Separation of ibuprofen, codeine phosphate, their degradation products and impurities by capillary electrophoresis I. Method development and optimization with fractional factorial design. J. Chromatogr. A., 1998, 798, 307-314.
62. Visky, D.; Kraszni, M.; Hosztafi, S.; Noszál, B. HPCE analysis of hydrolysing morphine derivatives. Quantitation of decomposition rate and mobility. Chromatographia, 2000, 51, 294-300.
63. Quarry, M.A.; Sebastian, D.S.; Diana, F. Investigation of 4,5-epoxymorphinan degradation during analysis by HPLC. J. Pharm. Biomed. Anal., 2002, 30, 99-104.
64. Cone, E.J.; Gorodetzky, C.W.; Daewin, W.D.; Buchwald, W.F. Stability of the 6,14-endo-ethanotetrahydrooripavine analgesics: acid-catalyzed rearrangement of buprenorphine. J. Pharm. Sci., 1984, 73, 243-246.
65. Schill, G.; Gustavii, K. Acid dissociation constants of morphine. Acta Pharm. Suec., 1964, 1, 24-35.
66. Avdeef, A.; Barrett, DA.; Shaw, PN.; Knaggs, RD.; Davis, SS. Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. J. Med. Chem., 1996, 4377-4381.
67. Barlow, R. B. The ionization of morphine, hydroxyamphetamine and (+)-tubocurarine chloride and a new method for calculating zwitterion constants. Br. J. Pharmacol., 1982, 75, 503-512.
68. Takács-Novák, K.; Avdeef, A. Interlaboratory study of log P determination by shake-flask and potentiometric methods. J. Pharm. Biomed. Anal., 1996, 14, 1405-1413.
69. Takácsné Novák, K.; Tokésné Kévesdi, M.; Szász, Gy. Amfoter gyógyszerek sav-bázis makro- és mikroegyensúlyainak vizsgálata. Magy Kém Folyóirat, 1994, 12, 538-545.
70. Jolliffe, G. O.; Ahmad, M. M. Ionization constants of morphinelike compounds: chemical structure. Bull. Narcot., 1971, 4, 37-40.
71. Plummer, JL; Cmielewski, PL; Reynolds, GD; Gourlay, GK; Cherry, DA. Influence of polarity on dose-response relationships of intrathecal opioids in rats. Pain, 1990, 40, 339-47.